TCL Archive Pediatric Oncology Groups Plan To Merge, Citing Greater Cost Efficiencies, Leverage August 7, 1998
TCL Archive RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment September 27, 2013